Delivery Order SPE2DB20D3101-SPE2DB24FQVW1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,694.10, is for the delivery of Lidocaine 5% Patches. This is a firm fixed-price delivery order contract with a completion date of February 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $1,644.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of May 10, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award, valued at $6,584.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a completion date of May 22, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was awarded on May 19, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award, valued at $5,843.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award, with ID SPE2DX15D2101|SPE2DX24F48SC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $24,653.90. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is December 8, 2023. The contract was awarded on December 7,...
- This federal contract award, valued at $2,978.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, with a completion date of May 3, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract was awarded on May 2, 2024, and was not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, over a period ending on January 11, 2024. The award has a ceiling value of $7,224.94 and is a Firm Fixed Price Delivery Order contract. The contract is not set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award with ID SPE2DB22D2005|SPE2DB23FJNJ7 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $4,469.10. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the Ultimate Completion Date is April 24, 2023. This contract is not designated as a Set-Aside....
- This federal contract award, valued at $3,857.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a completion date of May 8, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is the prime contractor for this delivery order contract, which is priced on a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lidocaine 5% Patch 30S. The contract, valued at $12,422.33, has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQVW1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,836.47, is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has a completion date of December 4, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various federal agencies, including the Department of Defense and Department of Veterans Affairs. The company holds significant Indefinite Delivery Contracts with the DLA Troop Support Medical, valued up to $999,999,999.00, as well as a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, to efficiently deliver essential pharmaceutical and medical commodities to support government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/1/23 |